Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study

<div>IL-29 in Graves’ disease without orbitopathy—GD without GO, Graves’ disease with GO—GD with GO and control subjects—CS. Values are expressed as median and interquartile range (IQR).</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study 